Figure 5
From: Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
SGRQ network meta-analysis results at 6 months: Difference in change from baseline (CFB) or odds ratio (OR) for responders versus placebo. Bars represent 95% Credible Interval; CFB = Change from baseline; FOR 12 = Formoterol 12 μg twice daily (BID); GPM 50 = Glycopyrronium 50 μg once daily (OD); IND 150 = Indacaterol 150 μg OD; IND 300 = Indacaterol 300 μg OD; OR = Odds ratio; SAL 50 = Salmeterol 50 μg BID; SGRQ = St. George’s Respiratory Questionnaire; TIO 5 = Tiotropium 5 μg OD; TIO 18 = Tiotropium 18 μg OD.